<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>For the treatment of 42 patients with different forms of atherosclerotic and postencephalitic <z:hpo ids='HP_0001300'>parkinsonism</z:hpo> the author used levopa drugs, medantane, cyclodol and parkopan in combination and separately </plain></SENT>
<SENT sid="1" pm="."><plain>The most stable improvement was obtained from a combination of levopa with cyclodol in patient with rigid-akynetic-<z:mp ids='MP_0000745'>trembling</z:mp> manifestations of <z:hpo ids='HP_0001300'>parkinsonism</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>The treatment by medantane increased the therapeutical effect in the patients with postencephalitic <z:hpo ids='HP_0001300'>parkinsonism</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="36" ids="29309">Methyl</z:chebi>-<z:chebi fb="0" ids="49168">dopa</z:chebi> and <z:chebi fb="5" ids="16709">pyridoxine</z:chebi> served as a corrector of levopa </plain></SENT>
<SENT sid="4" pm="."><plain>The studies on the blood content of <z:chebi fb="9" ids="15355">acetylcholine</z:chebi> and cholinesterase showed a growth of cholinolytic and cholinesterase activity in the blood </plain></SENT>
</text></document>